季度财报
Celcuity(CELC)05-16 05:05
$Celcuity(CELC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-019974 Act: 34 Size: 3 MB 网页链接
简介：Celcuity Inc.是一家明尼苏达公司，是一家细胞分析公司，该公司正在研究新的癌症亚型和商业化诊断测试，旨在显著提高用靶向治疗方案治疗的癌症患者的反应率。 该公司专有的CELx诊断平台目前是唯一的市售技术，可以使用患者的活肿瘤细胞来评估与癌症相关的细胞信号通路的功能状态。
| 今开：19.41 | 昨收：19.15 |
| 最高：19.77 | 最低：18.6 |
| 涨停价： | 跌停价： |
| 总市值：657443322 |
Celcuity(CELC)05-16 05:05
$Celcuity(CELC)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-019974 Act: 34 Size: 3 MB 网页链接
Celcuity(CELC)05-30 19:15
$Celcuity(CELC)$ 8-K Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01 Accession Number: 0001493152-24-021864 Act: 34 Size: 961 KB 网页链接
Celcuity(CELC)06-01 05:05
$Celcuity(CELC)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001493152-24-022227 Act: 34 Size: 610 KB 网页链接
Celcuity(CELC)06-11 05:05
$Celcuity(CELC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-001376 Act: 34 Size: 285 KB 网页链接
Celcuity(CELC)05-31 05:35
$Celcuity(CELC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001493152-24-022020 Act: 33 Size: 905 KB 网页链接
Celcuity(CELC)05-01 04:25
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-009051 Size: 35 KB 网页链接
Celcuity(CELC)06-13 04:25
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012489 Size: 21 KB 网页链接
Celcuity(CELC)06-07 04:25
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012034 Size: 20 KB 网页链接
Celcuity(CELC)06-07 04:25
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012035 Size: 18 KB 网页链接
Celcuity(CELC)05-16 04:25
$Celcuity(CELC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-019852 Act: 34 Size: 306 KB 网页链接
新浪医药2021-04-09 13:15
编译丨river
4月8日，据外媒报道，细胞分析公司Celcuity宣布与辉瑞公司达成全球许可协议，辉瑞将gedatolisib（一种1b期pan-PI3K / mTOR抑制剂）专有权授予给Celcuity。Gedatolisib正在临床开发中，用于治疗ER + / HER2-阴性的晚期或转移性乳腺癌患者。
根据许可协议条款，辉瑞向Celcuity提...查看全文
594stellababy2017-10-03 02:31
我刚刚关注了 $Celcuity Inc.(CELC)$ ，当前价 $11.97。查看全文
6666六六2017-09-22 00:46
$Celcuity Inc.(CELC)$ 这个新股有人看好吗查看全文
美股 美股开盘 | 三大指数涨跌不一，搜狐(SOHU.US)涨超13% 2021年4月9日 20:31:45 智通财经APP获悉，4月9日(周五)美股开盘，三大指数涨跌不一。截至发稿，道指涨0.18%，标普500指数跌0.03%，纳指跌0.41%。 个股消息 细胞分析公司Celcuit... 网页链接
格隆汇4月9日丨Celcuity(CELC.US)盘前大涨38.78%报19.86美元。公司周四表示，已与辉瑞公司签署了一项全球许可协议，获得了开发和商业化辉瑞Gedatolisib的全球许可。Gedatolisib正处于临床开发阶段，用于治疗某些类型的乳腺癌患者。Celcuity表示:“来自103... 网页链接
$Celcuity(CELC)$ D/A [Amend] Notice of Exempt Offering of Securities, item 06b Accession Number: 0001437749-24-021559 Act: 33 Size: 13 KB 网页链接
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-013012 Size: 14 KB 网页链接
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012489 Size: 21 KB 网页链接
$Celcuity(CELC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000921895-24-001376 Act: 34 Size: 285 KB 网页链接
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012032 Size: 9 KB 网页链接
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012035 Size: 18 KB 网页链接
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012034 Size: 20 KB 网页链接
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012036 Size: 14 KB 网页链接
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-012040 Size: 15 KB 网页链接
$Celcuity(CELC)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001493152-24-022227 Act: 34 Size: 610 KB 网页链接